U.S. research roundup: Biogen, Datadog, Tesla
BIIB•Analysts raised JPMorgan’s rating on Biogen to overweight from neutral and lifted its price target to $300 from $210. Jefferies raised price targets for Datadog to $300 from $260 and Tesla to $400 from $350, alongside rating and target changes for dozens of other U.S.-listed companies.
1. Selected analyst actions
JPMorgan raised Biogen to overweight from neutral and increased its price target to $300 from $210. Jefferies raised its price targets for Datadog to $300 from $260 and Tesla to $400 from $350.
2. Other companies covered
The roundup also included target-price increases for Marathon Petroleum and Phillips 66, as well as changes to ratings or price targets for dozens of other U.S.-listed companies. These included cuts to targets for several real estate companies, financial firms and automakers.
